Salvage chemotherapy in recurrent head and neck cancer: The institut gustave roussy experience

This publication has 23 references indexed in Scilit:

• Recurrent and/or metastatic head and neck squamous cell carcinoma: A clinical, univariate and multivariate analysis of response and survival with cisplatin‐based chemotherapy
  The Laryngoscope, 1991
• Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer
  Annals of Oncology, 1991
• Phase II Study of Cisplatin and Continuous-Infusion 5-Fluorouracil and Bleomycin for Recurrent and Metastatic Head and Neck Squamous-Cell Carcinoma
  American Journal of Clinical Oncology, 1990
• A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer
  Cancer, 1990
• A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
  British Journal of Cancer, 1990
• 96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemia
  European Journal of Cancer and Clinical Oncology, 1989
• Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck
  Cancer, 1987
• A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck
  Cancer, 1985
• Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
  Cancer, 1984
• Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer
  Cancer, 1979